DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Invega Sustenna (Paliperidone Palmitate) - Current Clinical Trials

 
 



Clinical Trials Related to Invega Sustenna (Paliperidone)

Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning [Recruiting]

The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia [Terminated]

Paliperidone ER(InvegaŽ) on Depressive Symptoms of Schizophrenia Patients [Recruiting]

A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate [Completed]

A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia [Completed]

A Pharmacokinetic Study of Paliperidone ER [Not yet recruiting]

Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder [Terminated]

Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants [Completed]

Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants [Completed]

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants [Completed]

Different Safety Profile of Risperidone and Paliperidone Extended-release [Completed]

An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia [Completed]

Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia [Recruiting]

PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia [Completed]

Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission [Completed]

A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With Schizophrenia [Completed]

Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER [Completed]

A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder [Completed]

Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD) [Completed]

A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men [Completed]

The Effect of Paliperidone Palmitate in Schizophrenia [Recruiting]

A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls [Terminated]

A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform [Recruiting]

An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia [Completed]

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia [Completed]

An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia [Completed]

Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder [Completed]

Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants [Completed]

A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia [Completed]

A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate [Completed]

A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia [Active, not recruiting]

A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia [Completed]

Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia [Completed]

Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia [Completed]

Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease [Completed]

Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia [Completed]

Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL) [Completed]

A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia [Completed]

An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia [Active, not recruiting]

A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia [Completed]

Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder. [Completed]

A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia [Completed]

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia [Completed]

A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia [Completed]

Study of Paliperidone ER in Adolescents and Young Adults With Autism [Completed]

Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics [Completed]

A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics [Completed]

A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients [Recruiting]

An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia [Completed]

A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder [Completed]

A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone [Completed]

A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia [Completed]

Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia [Completed]

Study Evaluating and Comparing Single Dose and Multiple Dose Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Adults. [Completed]

Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation [Completed]

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital [Withdrawn]

A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone [Completed]

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations [Completed]

A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR [Completed]

A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia [Completed]

A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function [Completed]

A Study of the Dose Proportionality of Extended Release Paliperidone [Completed]

European Long-acting Antipsychotics in Schizophrenia Trial [Recruiting]

A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER [Completed]

Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia [Completed]

Effects of Paliperidone Palmitate Versus Oral Antipsychotics on Clinical Outcomes and MRI Measures [Recruiting]

An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia [Completed]

A Study of the Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese Volunteers [Completed]

Paliperidone Palmitate Flexible Dosing in Schizophrenia [Completed]

Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years [Completed]

A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine [Completed]

A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia [Completed]

Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER) [Completed]

A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia. [Completed]

Brain Myelination Effects of Paliperidone Palmitate Versus Oral Risperidone in First Episode Schizophrenia [Not yet recruiting]

A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose [Completed]

Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder. [Completed]

An Efficacy and Safety Study of Paliperidone Palmitate in Participants With Schizophrenia [Completed]

A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function [Completed]

A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia [Completed]

A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder [Completed]

A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone [Completed]

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years [Terminated]

Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia [Completed]

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder [Completed]

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations [Completed]

Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia [Completed]

Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone [Completed]

A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients [Completed]

A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders [Recruiting]

Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia [Completed]

A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone [Completed]

Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate [Completed]

A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville [Completed]

A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone [Completed]

INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017